Skip to content
Screener

Halozyme Therapeutics HALO Deferred Revenue

Deferred Revenue at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$3.6M+28.6%
AptarGroup logo
AptarGroupATR
$79.8M-0.3%
Aquestive Therapeutics, Inc. logo
Aquestive Therapeutics, Inc.AQST
$1.09M+4.2%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$73.84M-2.7%
Arrowhead Research logo
Arrowhead ResearchARWR
$108.54M+151%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$6.12M-65.1%

Other financials

Income statement

See full
Revenue$481.0M+47.7%
Gross profit$401.8M+43.8%
Operating income$287.7M+42.1%
Net income$229.9M+39.2%
EPS (diluted)$1.90+42.9%

Balance sheet

See full
Cash & equivalents$164.0M+165%
Total debt$2.2B+41.6%
Total equity$143.5M-56.9%
Total assets$2.6B+25.5%

Cash flow

See full
Operating cash flow$240.9M+142%
CapEx$4.2M+167%
Free cash flow$236.7M+141%

Valuation

See full
Market cap$9.91B+36.0%
Enterprise value$11.93B+36.1%
P/E13.8×-3.9×
P/S6×-0.2×

Profitability

See full
Gross margin82.4%-1.8pp
Operating margin59.3%+9.0pp
Net margin47.9%+6.5pp
FCF margin48.5%+2.6pp

Returns & leverage

See full
Return on equity124.5%+12.7pp
Debt / equity15.2×+10.6×
Current ratio2.7×-5.7×

Where this comes from

Reported directly by Halozyme Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:RevenueRemainingPerformanceObligation.

The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001159036-26-000104

FAQ

What is Halozyme Therapeutics's deferred revenue?
Halozyme Therapeutics (HALO) reported deferred revenue of $4.4M in Q2 2026.
What is the long-term trend for Halozyme Therapeutics's deferred revenue?
Over 2 years (2020 to 2022), Halozyme Therapeutics's deferred revenue has grown at a -2.4% compound annual growth rate (CAGR), from $5.77M to $5.5M.
What does deferred revenue mean?
Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.

Ask your AI about Halozyme Therapeutics's deferred revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude